Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bayer Aktienges Ads (OP: BAYRY )

15.41 USD -0.10 (-0.64%)
Streaming Delayed Price Updated: 2:17 PM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 111,571
Open 15.64
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 15.51
Today's Range 15.38 - 15.70
52wk Range 11.65 - 21.05
Shares Outstanding 3,487,255,841
Dividend Yield 3.92%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Bayer's Exposure to Thousands of Cancer Lawsuits Persists as Victims' Lawyers Vow to Continue the Fight
Dallas law firm representing more than 4,000 vows to continue fight for those sickened by Roundup herbicide 
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bayer Aktiengesellschaft - BAYRY
From PR Newswire

Performance

YTD
+2.39%
+2.39%
1 Month
+0.49%
+0.49%
3 Month
+6.06%
+6.06%
6 Month
-7.81%
-7.81%
1 Year
-13.62%
-13.62%

More News

Read More
Selecta Biosciences/Asklepios Start Early-Stage Study To Assess ImmTOR In Gene Therapy
Tags FDA Penny Stocks Phase 1 Trial
From Benzinga
CureVac Shares Gain After UK Backs Company's Vaccine Development Efforts For COVID-19 Variants
Tags Market News BAYRY U/K/
From Benzinga
Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week
Tags Market News SBVCF Cannabis
From Benzinga
Here's Why FuelCell, Tesla, Workhorse, Nikola and Nio Stock Is Moving
Tags why it's moving LI NKLA
From Benzinga
CureVac Shares Rip Higher On Coronavirus Vaccine Deal With Bayer
Tags Health Care Trading Ideas Covid/19
From Benzinga
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Bayer Aktiengesellschaft and Encourages Investors with Losses of $100,000 to Contact the Firm
From Business Wire News Releases
Bayer Sells $1.6B Stake In Elanco Animal Health
Tags Asset Sales Market News Bloomberg
From Benzinga
Bayer Acquires AskBio For $4 Billion To Strengthen Its Gene Therapy Platform
Tags News gene therapy General
From Benzinga
Elanco Animal Health Earnings Mixed, Sales Guidance Lags Expectations
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.